Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18+
SponsorFondazione Policlinico Universitario Agostino Gemelli IRCCS
About this trial
The overall objective of this study is to evaluate the prognostic role of ultrasound and laboratory parameters, specifically their potential ability to predict severe forms of preeclampsia and adverse maternal-fetal outcomes.
In particular, the aim of the present research is to obtain data on the prognostic value of ultrasonographic and biochemical parameters in patients with hypertensive disorders of pregnancy.
Eligibility criteria
Qualifiers
Pregnancies complicated by preeclampsia or gestational hypertension ≥22 weeks
Age ≥18 years
Signed informed consent
Disqualifiers
intrauterine fetal demise
Major fetal anomalies or chromosomal abnormalities
Maternal cardiac disease or ongoing cardiologic therapy
Chronic kidney disease
Trial design
Treatments tested in this trial
- Doppler evaluation
Treatment groups
120 Participants
are divided into 1 treatment groupLocations
Sponsors and collaborators
Source ClinicalTrials.gov